Efficacy of linezolid in the treatment of tuberculous meningitis: a meta-analysis
Authors:
Open Access
- 29 June 2024
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (3) , 1038-1042
Abstract
Introduction: Tuberculous meningitis (TBM) is a severe extra-pulmonary tuberculosis with high fatality. This meta-analysis aimed to assess the impact of linezolid on TBM treatment outcomes.Methods: We searched multiple databases for studies published up to May 18, 2024 comparing the effects of linezolid on TBM. Meta-analysis was conducted using Review Manager 5.4.Results: Our findings indicated that linezolid may reduce treatment failure risk (RR = 0.42 (0.20, 0.89), p = 0.02) and improve temperature recovery (RR = 1.56 (1.21, 2.02), p < 0.001) in TBM patients.Conclusions: The analysis suggests a positive association between linezolid treatment and therapeutic improvements, with no significant adverse reactions reported.Keywords
This publication has 19 references indexed in Scilit:
- Validation of a quantitative liquid chromatography tandem mass spectrometry assay for linezolid in cerebrospinal fluid and its application to patients with HIV-associated TB-meningitisHeliyon, 2023
- Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trialTuberculosis, 2023
- A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM TrialClinical Infectious Diseases, 2022
- Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of TuberculosisThe Journal of Infectious Diseases, 2020
- Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human TuberculosisClinical Pharmacokinetics, 2019
- Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscessInternational Journal of Antimicrobial Agents, 2016
- Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculous MeningitisThe Pediatric Infectious Disease Journal, 2016
- Tuberculous meningitis: more questions, still too few answersThe Lancet Neurology, 2013
- Cerebrospinal fluid concentrations of antituberculosis agents in adults and childrenTuberculosis, 2010
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996